AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder that causes muscle weakness, numbness, and even paralysis.

A new study from the University of Minnesota and Mayo Clinic has found that people who are hospitalized for infections face a ...

Researchers have used artificial intelligence to identify 25 new protein compounds that can kill bacteria and fungi, ...

In observance of Black HIV/AIDS Awareness Day, we are called to reflect on the ongoing epidemic and its disproportionate ...

As federal health websites and databases are taken offline under Trump administration orders, physicians turn to archived and alternative sources for information. Here are useful resources.

New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment. UTIs are one of the most prevalent bacterial infections ...

With usually high cases of the "stomach bug" this year, these are the norovirus symptoms you need to be aware of, including ...

In South Africa, a 36-year-old living with HIV since childhood fears she will lose access to treatment due to Trump’s policy.

A new study from the University of Basel, published in Nature, challenges the conventional understanding of antibiotic ...

According to the CDC, nearly three million people in the U.S. get antibiotic resistant infections every year, and around ...